Terms: = Breast cancer AND TFRC, P02786, 7037, ENSG00000072274, TFR1, CD71 AND Treatment
28 results:
1. Correlation between ferroptosis and adriamycin resistance in breast cancer regulated by transferrin receptor and its molecular mechanism.
Yu X; Cheng L; Liu S; Wang M; Zhang H; Wang X; Zhang H; Yang Z; Wu S
FASEB J; 2024 Mar; 38(5):e23550. PubMed ID: 38466338
[TBL] [Abstract] [Full Text] [Related]
2. The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study.
Yıldırım HÇ; Kutlu Y; Mutlu E; Aykan MB; Korkmaz M; Yalçın S; Şakalar T; Celayir ÖM; Kayıkçıoğlu E; Aslan F; Hafızoğlu E; Altıntaş YE; Keskinkılıç M; Chalabiyev E; Çelebi A; Dursun B; Kapar C; Özen M; Acar Ö; Dülgar Ö; Kut E; Biter S; Kus F; Almuradova E; Erdoğan AP; Saray S; Güven DC; Şimşek ET; Üskent N; Kemal Y; Çakar B; Açıkgöz Ö; Kılıçkap S; Aksoy S
Int J Clin Oncol; 2024 Mar; 29(3):258-265. PubMed ID: 38310597
[TBL] [Abstract] [Full Text] [Related]
3. Paris saponin VII promotes ferroptosis to inhibit breast cancer via Nrf2/GPX4 axis.
Yan C; Xuan F
Biochem Biophys Res Commun; 2024 Feb; 697():149524. PubMed ID: 38252991
[TBL] [Abstract] [Full Text] [Related]
4. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
[TBL] [Abstract] [Full Text] [Related]
5. Expression of genes related to iron homeostasis in breast cancer.
Mutlu T; Ozoran E; Trabulus DC; Talu CK; Erhan D; Mete M; Guven M
Mol Biol Rep; 2023 Jun; 50(6):5157-5163. PubMed ID: 37119411
[TBL] [Abstract] [Full Text] [Related]
6. Co-Encapsulation of Hydrophilic and Hydrophobic Drugs into Human H Chain Ferritin Nanocarrier Enhances Antitumor Efficacy.
Ning C; Dong Y; Yang K; Li X; Wang F; Zhang Y
ACS Biomater Sci Eng; 2023 May; 9(5):2572-2583. PubMed ID: 37071410
[TBL] [Abstract] [Full Text] [Related]
7. A Novel Immune-Related Signature to Predict Prognosis and Immune Infiltration of Cervical cancer.
Lin Y; Zhang R; Pan H; Li Y
Med Sci Monit; 2023 Mar; 29():e938660. PubMed ID: 36973995
[TBL] [Abstract] [Full Text] [Related]
8. Long term pregnancy outcomes of women with cancer following fertility preservation: A systematic review and meta-analysis.
Xu Z; Ibrahim S; Burdett S; Rydzewska L; Al Wattar BH; Davies MC
Eur J Obstet Gynecol Reprod Biol; 2023 Feb; 281():41-48. PubMed ID: 36535069
[TBL] [Abstract] [Full Text] [Related]
9. TMEM189 promotes breast cancer through inhibition of autophagy-regulated ferroptosis.
Liu J; Sun M; Sun Y; Li H
Biochem Biophys Res Commun; 2022 Sep; 622():37-44. PubMed ID: 35843092
[TBL] [Abstract] [Full Text] [Related]
10. Biomarker Profiling Revealed Carcinoembryonic Antigen as a Target of Artesunate in a Ductal breast cancer Patient.
Saeed MEM; Drif AI; Efferth T
Anticancer Res; 2022 Jul; 42(7):3483-3494. PubMed ID: 35790273
[TBL] [Abstract] [Full Text] [Related]
11. Phenazine derivatives attenuate the stemness of breast cancer cells through triggering ferroptosis.
Yang Y; Lu Y; Zhang C; Guo Q; Zhang W; Wang T; Xia Z; Liu J; Cheng X; Xi T; Jiang F; Zheng L
Cell Mol Life Sci; 2022 Jun; 79(7):360. PubMed ID: 35690642
[TBL] [Abstract] [Full Text] [Related]
12. Intraductal administration of transferrin receptor-targeted immunotoxin clears ductal carcinoma in situ in mouse models of breast cancer-a preclinical study.
Wang G; Kumar A; Ding W; Korangath P; Bera T; Wei J; Pai P; Gabrielson K; Pastan I; Sukumar S
Proc Natl Acad Sci U S A; 2022 Jun; 119(24):e2200200119. PubMed ID: 35675429
[TBL] [Abstract] [Full Text] [Related]
13. High activity and low toxicity of a novel cd71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors.
Falvo E; Damiani V; Conti G; Boschi F; Messana K; Giacomini P; Milella M; De Laurenzi V; Morea V; Sala G; Fracasso G; Ceci P
J Exp Clin Cancer Res; 2021 Feb; 40(1):63. PubMed ID: 33568214
[TBL] [Abstract] [Full Text] [Related]
14. IMMUNEPOTENT CRP plus doxorubicin/cyclophosphamide chemotherapy remodel the tumor microenvironment in an air pouch triple-negative breast cancer murine model.
Santana-Krímskaya SE; Franco-Molina MA; Zárate-Triviño DG; Prado-García H; Zapata-Benavides P; Torres-Del-Muro F; Rodríguez-Padilla C
Biomed Pharmacother; 2020 Jun; 126():110062. PubMed ID: 32172064
[TBL] [Abstract] [Full Text] [Related]
15. Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery.
Breen AF; Scurr D; Cassioli ML; Wells G; Thomas NR; Zhang J; Turyanska L; Bradshaw TD
Int J Nanomedicine; 2019; 14():9525-9534. PubMed ID: 31824148
[TBL] [Abstract] [Full Text] [Related]
16. Deferoxamine Enhanced Mitochondrial Iron Accumulation and Promoted Cell Migration in Triple-Negative MDA-MB-231 breast cancer Cells Via a ROS-Dependent Mechanism.
Chen C; Wang S; Liu P
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597263
[TBL] [Abstract] [Full Text] [Related]
17. Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor.
Yu H; Yang C; Jian L; Guo S; Chen R; Li K; Qu F; Tao K; Fu Y; Luo F; Liu S
Oncol Rep; 2019 Aug; 42(2):826-838. PubMed ID: 31173262
[TBL] [Abstract] [Full Text] [Related]
18. N-(p-coumaroyl) serotonin induces cell cycle arrest and apoptosis in breast cancer cells.
Mitsis M; Alexiou GA; Vartholomatos E; Markopoulos G; Lazari D; Hodaj E; Nastos D; Zagorianakou P; Galani V; Kyritsis AP
J BUON; 2018; 23(1):129-133. PubMed ID: 29552772
[TBL] [Abstract] [Full Text] [Related]
19. H-Ferritin Enriches the Curcumin Uptake and Improves the Therapeutic Efficacy in Triple Negative breast cancer Cells.
Pandolfi L; Bellini M; Vanna R; Morasso C; Zago A; Carcano S; Avvakumova S; Bertolini JA; Rizzuto MA; Colombo M; Prosperi D
Biomacromolecules; 2017 Oct; 18(10):3318-3330. PubMed ID: 28886247
[TBL] [Abstract] [Full Text] [Related]
20. H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer.
Mazzucchelli S; Truffi M; Baccarini F; Beretta M; Sorrentino L; Bellini M; Rizzuto MA; Ottria R; Ravelli A; Ciuffreda P; Prosperi D; Corsi F
Sci Rep; 2017 Aug; 7(1):7505. PubMed ID: 28790402
[TBL] [Abstract] [Full Text] [Related]
[Next]
